logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
N

Naga Chalasani

Indiana University

107H-index
855Paper Count
5.7WCitation Count
Published Papers 400
Publication Date
logo
Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis
errJournal of Hepatology
IF33
err2026-10-05
err0
errOAAI
errNaga P. Chalasani; Rebecca Taub; Robin Mogg; Dominic Labriola; Raul C. Camacho; Hang Zhang; Quentin M. Anstee
errShare
errSave
Age-Specific Associations of Polygenic Risk Scores With Advanced Fibrosis and Histological Activity in Biopsy-Proven MASLD
errLiver International
IF5.2
err2026-10-02
err0
errOAAI
errSamer Gawrieh; Jingyi Tan; Xiuqing Guo; Linus Schwantes-An; Marco Abreu; Callie J. Zaborenko; Eduardo Vilar-Gomez; Jeffrey B. Schwimmer; Jerome I. Rotter; Naga Chalasani
errShare
errSave
Short-Term Risk Stratification in Alcohol-Associated Hepatitis: Small HDL Particles and Inflammation Vulnerability Index Values Improve Model for End-Stage Liver Disease
errAlcohol-Clinical and Experimental Research
IF2.7
err2026-09-22
err0
errOAAI
errEduardo Vilar-Gomez; Margery A. Connelly; Vijay H. Shah; Irina Shalaurova; Jill M. Rafalko; Arun J. Sanyal; Naga P. Chalasani; Samer Gawrieh; TREAT Consortium
errShare
errSave
Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis
errClinical Gastroenterology and Hepatology
IF12
err2026-09-16
err0
PREAI
errVeeral Ajmera; Linus Schwantes-An; Luis Antonio Díaz; Callie Zaborenko; Katherine P. Yates; Naga P. Chalasani; Rohit Loomba
errShare
errSave
Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver Disease
errCancers
IF4.4
err2026-08-28
err0
errOAAI
errAmit G. Singal; Mark Camardo; Janelle J. Bruinsma; Elle Kielar-Grevstad; Naga Chalasani; Binu V. John
errShare
errSave
Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2026-08-27
err0
PREAI
errNaga Chalasani; Ismael Alvarez-Alvarez; Paul H. Hayashi; Raj Vuppalanchi; Marwan Ghabril; Ronald Kamusiime; Huiman Barnhart; Hao Niu; M. Isabel Lucena; Raul J. Andrade; for the Drug Induced Liver Injury Network
errShare
errSave
Addressing the Public Health Threat of Steatotic Liver Disease in Mexico
errArchives of Medical Research
IF3.4
err2026-07-01
err0
PREAI
errGarin, Maria Fernanda Bautista; Barquera, Simon; Castro-Narro, Graciela Elia; Margain, Astrid Ruiz; Macias-Rodriguez, Ricardo U.; Agirre-Garrido, Leire; Arellano, Mariana; Ramirez-Butanda, Eduardo; Chalasani, Naga; Lazarus, Jeffrey, V
errShare
errSave
The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial
errHepatology Communications
IF4.6
err2026-07-01
err0
PREAI
errYoder, Lindsay; Tapper, Elliot B.; Kalman, Richard; Rinella, Mary; Bendin, Nicole; Verma, Manisha; Pike, Francis; Chalasani, Naga; Nalumasu, Neha; Orman, Eric S.
errShare
errSave
DRESS Syndrome in Patients With Drug-Induced Liver Injury: Characteristics and HLA Risk Factors
errAmerican Journal of Gastroenterology
IF7.6
err2026-05-01
err3
PREAI
errRahnama-Moghadam, Sahand; Arora, Nitin; Vuppalanchi, Raj; Li, Yi Ju; Gu, Jiezhun; Barnhart, Huiman; Phillips, Elizabeth; Chalasani, Naga
errShare
errSave
Preventable Visits to the Emergency Department in Patients with Cirrhosis
errClinical and Translational Gastroenterology
IF3
err2026-01-01
err0
PREAI
errSwetha Parvataneni; Eric S. Orman; Qing Tang; Raj Vuppalanchi; Naga Chalasani; Nicholas Eric Harrison; Archita P. Desai
errShare
errSave
Prevalence, Genetic Risks, and Cardiovascular Outcomes of Metabolic and Alcohol-Associated Liver Disease in a Longitudinal Multiethnic US Cohort
errGastro Hep Advances
IF0
err2026-01-01
err0
errOAAI
errYao, Jie; Guo, Xiuqing; Tan, Jingyi; Zaborenko, Callie; Rotter, Jerome, I; Chalasani, Naga P.
errShare
errSave
Diet quality and physical activity lower alcohol-attributable liver-related mortality in US adults. Practical recommendations for clinicians
errJournal of Hepatology
IF33
err2025-11-26
err0
PREAI
errEduardo Vilar-Gomez; Naga Chalasani
errShare
errSave
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study
errThe Lancet
IF97.3
err2025-11-11
err0
PREAI
errMazen Noureddin; Stephen A Harrison; Rohit Loomba; Naim Alkhouri; Naga Chalasani; Muhammad Y Sheikh; Shaheen Tomah; Julio A Gutierrez; Silvia Urbina; John J Suschak; Randy Brown; Ozioma Odili; Jay Yang; Stephine Keeton; Guy Neff; Edward Mena; M Scot Roberts; Sarah K Browne; M Scott Harris
errShare
errSave
Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease
errGastroenterology Clinics of North America
IF3.9
err2025-11-07
err0
PREAI
errArka De; Naga Chalasani; Ajay Duseja
errShare
errSave
Female Sex is Protective Against MASLD With Clinically Significant Fibrosis in a Large Cross-sectional Cohort of Persons With HIV
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2025-11-01
err0
PREAI
errWegermann, Kara; Suzuki, Ayako; Sarmiento, Elisa; Boyd, Lakeisha; Li, Yang; Wilson, Laura A.; Lloyd, Audrey; Debroy, Paula; Price, Jennifer C.; Woreta, Tinsay; Crandall, Holly; Sterling, Richard K.; Loomba, Rohit; Chalasani, Naga; Lake, Jordan E.
errShare
errSave
The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus
errAMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY
IF5.9
err2025-10-01
err0
errOAAI
errSterling, Richard K.; Sternberg, Alice L.; Lake, Jordan E.; Naggie, Susanna; Heath, Sonya; Price, Jennifer C.; Wilson, Laura; Crandall, Holly; Gawrieh, Samer; Chalasani, Naga; Loomba, Rohit; Sulkowski, Mark
errShare
errSave
Genetic and non-genetic drivers of histological progression and regression in MASLD
errJournal of Hepatology
IF33
err2025-09-24
err0
PREAI
errEduardo Vilar-Gomez; Katherine P. Yates; David E. Kleiner; Cynthia Behling; Oscar W. Cummings; Laura A. Wilson; Tiebing Liang; Chaowapong Jarasvaraparn; Rohit Loomba; Jeffrey B. Schwimmer; Arun J. Sanyal; Jay Hoofnagle; Naga Chalasani
errShare
errSave
Natural history and development of a novel composite endpoint in patients with alcohol-associated hepatitis: Data from a prospective multicenter study
errHEPATOLOGY
IF15.8
err2025-09-01
err3
PREAI
errDasarathy, Srinivasan; Tu, Wanzhu; Welch, Nicole; Gawrieh, Samer; Yu, Yunpeng; Tang, Qing; Kettler, Carla; Sanyal, Arun J.; Szabo, Gyongyi; Shah, Vijay H.; Bataller, Ramon; Nagy, Laura E.; Mcclain, Craig J.; Chalasani, Naga; Kerr, Thomas; Mitchell, Mack C.
errShare
errSave
Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States
errJournal of Hepatology
IF33
err2025-08-27
err0
PREAI
errEduardo Vilar-Gomez; Lauren Nephew; Samer Gawrieh; Raj Vuppalanchi; Carla Kettler; Francis Pike; Wanzhu Tu; Niharika Samala; Suthat Liangpunsakul; Naga Chalasani
errShare
errSave
Biological age, PNPLA3 and risk of metabolic dysfunction-associated steatotic liver disease
errClinical Gastroenterology and Hepatology
IF12
err2025-08-25
err0
PREAI
errSamer Gawrieh; Jie Yao; Xiuqing Guo; Anna Mae Diehl; Jerome I. Rotter; Naga P. Chalasani
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
M
Mark J. Daly
H-index: 224 · Papers: 1.2K
S
Stefan Schreiber
H-index: 192 · Papers: 1.9K
C
Cisca Wijmenga
H-index: 169 · Papers: 996
A
Arun J. Sanyal
H-index: 166 · Papers: 1.4K
M
Michael P. Manns
H-index: 163 · Papers: 2.1K
View more